- Home
- CHRD vs MMSI Comparison
CHRD vs MMSI Comparison
Compare CHRD & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRD
- MMSI
- Stock Information
- Founded
- CHRD 2007
- MMSI 1987
- Country
- CHRD United States
- MMSI United States
- Employees
- CHRD N/A
- MMSI N/A
- Industry
- CHRD Oil & Gas Production
- MMSI Medical/Dental Instruments
- Sector
- CHRD Energy
- MMSI Health Care
- Exchange
- CHRD Nasdaq
- MMSI Nasdaq
- Market Cap
- CHRD 5.5B
- MMSI 5.8B
- IPO Year
- CHRD 2010
- MMSI 1990
- Fundamental
- Price
- CHRD $90.00
- MMSI $95.03
- Analyst Decision
- CHRD Buy
- MMSI Buy
- Analyst Count
- CHRD 12
- MMSI 9
- Target Price
- CHRD $153.67
- MMSI $109.11
- AVG Volume (30 Days)
- CHRD 778.2K
- MMSI 611.3K
- Earning Date
- CHRD 05-06-2025
- MMSI 04-24-2025
- Dividend Yield
- CHRD 7.29%
- MMSI N/A
- EPS Growth
- CHRD N/A
- MMSI 17.19
- EPS
- CHRD 15.19
- MMSI 2.04
- Revenue
- CHRD $5,036,741,000.00
- MMSI $1,388,357,000.00
- Revenue This Year
- CHRD N/A
- MMSI $11.31
- Revenue Next Year
- CHRD $0.94
- MMSI $6.09
- P/E Ratio
- CHRD $5.93
- MMSI $46.61
- Revenue Growth
- CHRD 31.78
- MMSI 8.19
- 52 Week Low
- CHRD $79.83
- MMSI $80.02
- 52 Week High
- CHRD $188.02
- MMSI $111.45
- Technical
- Relative Strength Index (RSI)
- CHRD 42.35
- MMSI 46.91
- Support Level
- CHRD $88.27
- MMSI $93.86
- Resistance Level
- CHRD $92.22
- MMSI $97.18
- Average True Range (ATR)
- CHRD 2.15
- MMSI 1.85
- MACD
- CHRD -0.26
- MMSI -0.20
- Stochastic Oscillator
- CHRD 14.18
- MMSI 18.48
About CHRD Chord Energy Corporation
Chord Energy Corp is an independent exploration and production company. The company acquires, exploits, develops, and explores crude oil, natural gas, and natural gas liquids in the Williston Basin.
About MMSI Merit Medical Systems Inc.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.